Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Venous Thromboembolism 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Lynch syndrome I (site-specific colonic cancer) 1Liver Cirrhosis 1Fibrosis 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Paclitaxel 8Carboplatin 7Tirzepatide 3Observation 3Cisplatin 3pembrolizumab 2dostarlimab 2Megestrol Acetate 2Medroxyprogesterone Acetate 2Blood Specimen Collection 2trilaciclib 1toripalimab 1tislelizumab 1sintilimab 1semaglutide 1olaparib 1montelukast 1inavolisib 1enfortumab vedotin 1ceralasertib 1camrelizumab 1apatinib 1anlotinib 1Watchful Waiting 1Vaginal Smears 1Topotecan 1Tablets 1Specimen Handling 1Sensitivity Training Groups 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Endometrial Neoplasms × Aspirin × Clear all
NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Mayo Clinic

Phase 4 Not yet recruiting
25 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡